Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).
Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).
复制标题
DOI:
10.1177/1740774510373497
复制
发表时间:
2010
期刊:
影响因子:
--
通讯作者:
T1DGC
中科院分区:
文献类型:
--
作者:
Hilner JE;Perdue LH;Sides EG;Pierce JJ;Wägner AM;Aldrich A;Loth A;Albret L;Wagenknecht LE;Nierras C;Akolkar B;T1DGC
Background and Purpose The Type 1 Diabetes Genetics Consortium (T1DGC) is an international project whose primary aims are to: (a) discover genes that modify type 1 diabetes risk; and (b) expand upon the existing genetic resources for type 1 diabetes research. The initial goal was to collect 2500 affected sibling pair (ASP) families worldwide. Methods T1DGC was organized into four regional networks (Asia-Pacific, Europe, North America, and the United Kingdom) and a Coordinating Center. A Steering Committee, with representatives from each network, the Coordinating Center, and the funding organizations, was responsible for T1DGC operations. The Coordinating Center, with regional network representatives, developed study documents and data systems. Each network established laboratories for: DNA extraction and cell line production; human leukocyte antigen genotyping; and autoantibody measurement. Samples were tracked from the point of collection, processed at network laboratories and stored for deposit at National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repositories. Phenotypic data were collected and entered into the study database maintained by the Coordinating Center. Results T1DGC achieved its original ASP recruitment goal. In response to research design changes, the T1DGC infrastructure also recruited trios, cases, and controls. Results of genetic analyses have identified many novel regions that affect susceptibility to type 1 diabetes. T1DGC created a resource of data and samples that is accessible to the research community. Limitations Participation in T1DGC was declined by some countries due to study requirements for the processing of samples at network laboratories and/or final deposition of samples in NIDDK Central Repositories. Re-contact of participants was not included in informed consent templates, preventing collection of additional samples for functional studies. Conclusions T1DGC implemented a distributed, regional network structure to reach ASP recruitment targets. The infrastructure proved robust and flexible enough to accommodate additional recruitment. T1DGC has established significant resources that provide a basis for future discovery in the study of type 1 diabetes genetics.
登录
查看更多内容
DOI:
10.1177/1740774510373492
发表时间:
2010
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
Hall MA;King NM;Perdue LH;Hilner JE;Akolkar B;Greenbaum CJ;McKeon C;T1DGC
通讯作者:
T1DGC
影响因子:
30.8
作者:
Barrett, Jeffrey C.;Clayton, David G.;Concannon, Patrick;Akolkar, Beena;Cooper, Jason D.;Erlich, Henry A.;Julier, Cecile;Morahan, Grant;Nerup, Jorn;Nierras, Concepcion;Plagnol, Vincent;Pociot, Flemming;Schuilenburg, Helen;Smyth, Deborah J.;Stevens, Helen;Todd, John A.;Walker, Neil M.;Rich, Stephen S.
通讯作者:
Rich, Stephen S.
DOI:
10.1111/j.1463-1326.2008.00997.x
发表时间:
2009-02
期刊:
Diabetes, obesity & metabolism
影响因子:
--
作者:
Brown WM;Pierce J;Hilner JE;Perdue LH;Lohman K;Li L;Venkatesh RB;Hunt S;Mychaleckyj JC;Deloukas P;Type 1 Diabetes Genetics Consortium
通讯作者:
Type 1 Diabetes Genetics Consortium
DOI:
10.1016/s0197-2456(01)00179-9
发表时间:
2002-04-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
Emery, S;Abrams, DI;Neaton, JD
通讯作者:
Neaton, JD
影响因子:
2.7
作者:
Rosinger, Silke;Nutland, Sarah;Steffes, Michael W.
通讯作者:
Steffes, Michael W.